AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2024
Nov 12, 2024
29821_dirs_2024-11-12_3cb538f1-0716-438e-b902-5b87e3833059.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-11-08
Reporting Person: Sorenson John Bradley (EVP, Global Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-08 | Common Stock | M | 17362.0000 | $24.5500 | Acquired | 70286.0000 | Direct |
| 2024-11-08 | Common Stock | S | 30580.0000 | $87.6577 | Disposed | 39706.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | Stock Option (Right to Buy) | $24.5500 | M | 17362.0000 | Disposed | 2027-02-28 | Common Stock (17362.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $87.324 to $87.94, inclusive. The reporting person undertakes to provide upon request bythe U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.